What Have Slow Progressors Taught Us About T1D—Mind the Gap!

PURPOSE OF REVIEW: Progression rate from islet autoimmunity to clinical diabetes is unpredictable. In this review, we focus on an intriguing group of slow progressors who have high-risk islet autoantibody profiles but some remain diabetes free for decades. RECENT FINDINGS: Birth cohort studies show...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillespie, Kathleen M., Long, Anna E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2019
Materias:
Pathogenesis of Type 1 Diabetes (A Pugliese and SJ Richardson, Section Editors)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733826/
https://www.ncbi.nlm.nih.gov/pubmed/31501992
http://dx.doi.org/10.1007/s11892-019-1219-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6733826/
https://www.ncbi.nlm.nih.gov/pubmed/31501992
http://dx.doi.org/10.1007/s11892-019-1219-1

Ejemplares similares